ImmuCell Sees Q3 Sales $8.000M

Benzinga Newsdesk www.benzinga.com Neutral 86.0%

Neg 0% Neu 86% Pos 0%

ImmuCell (NASDAQ:ICCC) sees Q3 sales of $8.000 million.

Comments

No comments yet. Be the first!